ABOUT US

Chad Harman is a 25-year cannabis and health insurance executive possessing unique leadership experience across operations, manufacturing, finance, product development, etc. Chad’s strength lies in focused corporate strategies to maximize efficiency and profitability.

Dr. Anish Tuteja is a Professor of Materials Science and Engineering, Chemical Engineering, and Macromolecular Science and Engineering at the University of Michigan. His work has led to over 20 patents and patent disclosures.

Michael Hlavsa has 44 years of executive and financial experience, receiving designations of CPA, certified internal auditor, and chartered global management accountant. He’s been an officer and director of numerous publicly traded companies on the NYSE, NASDAQ and OTCBB.

Julian E. Bailes, MD is a recognized leader in the field of neurosurgery and the impact of brain injury on brain function. He’s been instrumental in the understanding of of Chronic Traumatic Encephalopathy (CTE). He was portrayed by the actor Alec Baldwin in the movie Concussion.

Dr. Thomas Cabell is a cardiologist and is affiliated with the Centennial Heart group. Dr. Cabell is passionate about bringing awareness to and understanding the importance of emotional/mental health as it relates to physical health and disease.

Dr. Tony Strickland is a board-certified neuropsychologist and a retired associate clinical professor of neurology at the UCLA David Geffen School of Medicine. Dr. Strickland established the Center for Postconcussion Syndrome and PTSD Treatment.

Dr. Ronald Aung-Din practices General Neurology and Neuro-Psychiatry in Sarasota, Florida. He is board-certified by the American Board of Psychiatry and Neurology and a member of the American Academy of Neurology. He has participated as Principal Investigator in over 50 industry-sponsored clinical trials.

Dr. Anish Dhanarajan has Ph.D. in Biomedical Engineering/Chemical Engineering from the University of Minnesota. Anish managed formulation development at companies such as Pfizer, GSK, Mallinckrodt, and CorePharma. Anish is an expert in complex oral and parenteral product development and manufacturing processes.

Dr. Aric Logsdon is a biomedical researcher with expertise in preclinical drug discovery for human neurological disease. Aric earned his PhD in Pharmaceutical Sciences from West Virginia University in 2016 and completed Postdoctoral training at the University of Washington. He has over 50 peer-reviewed publications in scientific journals.

Kevin Harrington is an entrepreneur, investor, business executive and best-selling author. He was one of the original members and investors (“sharks”) on the hit TV series Shark Tank. Harrington has been involved in over 500 product launches that have resulted in over $5 billion in sales.

Kaia brings 20 years of PR and marketing work in Silicon Valley for clients such as Google, Twilio, and Doctor On Demand. She is an entrepreneur, film producer, and bestselling author of The Joy Plan – a practical guide to the neuroscience of joy – which was featured on the TODAY Show.

Michael Gurin is a 25-year veteran of technology and business development. Gurin has been instrumental in creating the vision and technology road maps for coatings and membrane technologies through the use of integrated solutions advance surface coatings.  Gurin holds more than 80 U.S. patents and pending applications, plus additional international patent filings.

Dr. Kutzko has entrepreneurial experience in addition to consultancy and senior level operations management experience in the delivery of USP 795 and USP 797 compounding, home infusion services, specialty pharmacy services and medical devices. He also had full P&L oversight and responsibility for pharmacy operations throughout the southeastern U.S.

Dr. Zachary Clayton is an experienced researcher with expertise in designing fully translational preclinical studies that allow for maximum efficiency while creating reliable, applicable results intended to directly benefit human health. Dr. Clayton is a sought-after conference presenter and guest lecturer, and his research expertise is evidenced by authoring or co-authoring more than 35 peer-reviewed research publications to date.

Mr. Yerace is a co-founder of Coeptis Pharmaceuticals and serves as the Vice President of Operations. Dan is the key strategist responsible for supply chain management, business development, portfolio management, and corporate strategy.

Dr. Anish Dhanarajan has Ph.D. in Biomedical Engineering/Chemical Engineering from the University of Minnesota. Anish managed formulation development at companies such as Pfizer, GSK, Mallinckrodt, and CorePharma. Anish is an expert in complex oral and parenteral product development and manufacturing processes.

Francesca Minale manages all of Vici’s regulatory work, including p-INDs, INDs, and ANDA filings. Francesca also oversees the QA department to ensure GMP compliance is maintained.

Francesca worked as a formulation development scientist and manager at CorePharma and Wes Pharma prior to the founding of Vici Health Sciences. Francesca is well versed in formulation, quality, and FDA regulatory requirements, and brings a high-energy creative dynamic to the work-place.

Francesca graduated with a Bachelor’s in Biological/Biosystems Engineering and a Master’s in Biomedical Engineering from Cornell University.

Mr. Mehalick is a co-founder of Coeptis Pharmaceuticals and serves as Chief Executive Officer. Dave is responsible for implementing long and short-term initiatives and overseeing fundraising planning and implementation.

Christine Sheehy is a pharmaceutical business leader with over 25 years of experience. Most recently, Ms. Sheehy has served as SVP of Global Integration for MeiraGTx and SVP of Operations for Kadmon Pharmaceuticals leading the global supply chain, distribution, and IT organizations.

Gary Conte serves as Coeptis’ Senior Vice President of Sales and Marketing, responsible for all business activities aligning with commercialization of the company’s drug products. Gary has held a variety of senior management roles, predominately in start-up pharmaceutical companies, many of which, have become highly successful. His expertise spans critical aspects of commercial product development, including sales, marketing, training, operations, managed care, sales analytics, and reporting.